© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 13, 2021
It’s possible that C diff could be a marker for frailty in geriatric patients.
January 09, 2021
Using piperacillin/tazobactam increases the risk for acute kidney injury, and this risk can be exacerbated by concurrent vancomycin.
January 07, 2021
Anastomotic leak can increase morbidity, mortality, and length and cost of hospital stays.
January 06, 2021
December 31, 2020
Investigators compared the 2010 and 2017 IDSA and SHEA guidelines to identify which better predicted C diff patients’ severity and mortality.
December 23, 2020
The investigators called their findings the “opposite of what was expected.”
December 21, 2020
Experts offered their advice on 2 domains, topic identification and ranking of priorities, for pediatric research realms.
November 19, 2020
C. diff infections have decreased during the ongoing pandemic.
November 12, 2020
The estimated the prevalence of C diff infections is about 40 in 30,000 for the sickle cell disease group and about 5000 in 11.8 million for the non-sickle cell disease group.
November 11, 2020
Longer studies are needed to determine the effectiveness and durability of CDI interventions.